The 20 Best Castleman Disease Doctors in Maryland, US

Ramya Meenakshi is an Oncologist in Bethesda, Maryland. Dr. Meenakshi is rated as an Elite provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Castleman Disease, Lymphoid Hyperplasia, Adult Soft Tissue Sarcoma, and Multicentric Castleman Disease (MCD).

Richard Little is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Little is rated as a Distinguished provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Kaposi Sarcoma, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Bone Marrow Transplant.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia.

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy.

John Wallmark is a Hematologist Oncology provider in Rockville, Maryland. Dr. Wallmark is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer.

Peter Graze is an Oncologist in Annapolis, Maryland. Dr. Graze is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Maura Manion is a primary care provider, practicing in Infectious Disease in Bethesda, Maryland. Dr. Manion is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are HIV/AIDS, Castleman Disease, Kaposi Sarcoma, and Hemophagocytic Lymphohistiocytosis.

Wyndham Wilson is an Oncologist in Bethesda, Maryland. Dr. Wilson is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

Giovanna Tosato is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Tosato is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Kaposi Sarcoma, Lymphoid Hyperplasia, Castleman Disease, and Multicentric Castleman Disease (MCD).

Richard Schraeder is a Hematologist and an Oncologist in Towson, Maryland. Dr. Schraeder is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.

Elyse Michelson is a primary care provider, practicing in Internal Medicine in Reisterstown, Maryland. Dr. Michelson is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are High Cholesterol, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Bhargavi Pulluri is an Oncologist in Baltimore, Maryland. Dr. Pulluri is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome.

Justinian Ngaiza is an Oncologist in Salisbury, Maryland. Dr. Ngaiza is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Von Willebrand Disease (VWD), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Ling Yang is a primary care provider, practicing in Family Medicine in Gaithersburg, Maryland. Dr. Yang is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Obesity, Type 2 Diabetes (T2D), Hepato-Pancreato-Biliary Surgery, and Endoscopy.

Duosha Hu is a primary care provider, practicing in Internal Medicine in Silver Spring, Maryland. Dr. Hu is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Multicentric Castleman Disease (MCD), Kaposi Sarcoma, Castleman Disease, and Sickle Cell Disease.

Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Djordje Atanackovic is a Hematologist in Baltimore, Maryland. Dr. Atanackovic is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.